{"organizations": [], "uuid": "df881c46d01d943a6d0101bb9618d35a38c2a5ce", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180524.html", "section_title": "Archive News &amp; Video for Thursday, 24 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/india-virus-vaccine/global-group-taps-u-s-biotechs-to-speed-work-on-nipah-vaccine-idUSL5N1SV3JS", "country": "US", "domain_rank": 408, "title": "Global group taps U.S. biotechs to speed work on Nipah vaccine", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.027, "site_type": "news", "published": "2018-05-24T18:38:00.000+03:00", "replies_count": 0, "uuid": "df881c46d01d943a6d0101bb9618d35a38c2a5ce"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/india-virus-vaccine/global-group-taps-u-s-biotechs-to-speed-work-on-nipah-vaccine-idUSL5N1SV3JS", "ord_in_thread": 0, "title": "Global group taps U.S. biotechs to speed work on Nipah vaccine", "locations": [], "entities": {"persons": [{"name": "ben hirschler", "sentiment": "none"}, {"name": "edmund blair", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "london", "sentiment": "none"}, {"name": "karnataka", "sentiment": "none"}, {"name": "kerala", "sentiment": "none"}, {"name": "india", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "profectus biosciences", "sentiment": "none"}, {"name": "coalition for epidemic preparedness innovations", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "LONDON, May 24 (Reuters) - A global coalition set up a year ago to fight epidemics has struck a $25 million deal with two U.S. biotech companies to accelerate work on a vaccine against the brain-damaging Nipah virus that has killed at least 11 people in India.\nThe Coalition for Epidemic Preparedness Innovations said on Thursday that Profectus BioSciences and Emergent BioSolutions would receive up to $25 million to advance development and manufacturing of a shot against the bat-borne disease.\nThere is currently no vaccine for Nipah.\nThe death toll from the latest outbreak in Kerala rose to 11 on Wednesday as Indian health officials said they were checking on two suspected cases in the neighbouring state of Karnataka. (Reporting by Ben Hirschler Editing by Edmund Blair)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-24T18:38:00.000+03:00", "crawled": "2018-05-25T16:29:23.038+03:00", "highlightTitle": ""}